Table 3.
Impact of treatment on intermediate outcomes
| hCG | LH | P | |
| Duration of stimulation (days) mean (SD) |
10.8 (1.9) |
11.1 (1.2) |
0.240 |
| E2 on the day of hCG (pg/ml) median (25th - 75th percentile) |
1888 (1119, 2118) |
720 (530, 1825) |
0.003 |
| Total rFSH dose/patient mean (SD) |
2940 (1231) |
4261 (1090) |
<0.001 |
| Number of follicles median (25th - 75th percentile) |
7 (5,9) |
4 (3,7) |
<0.001 |
| Oocytes number median (25th - 75th percentile) |
6 (4,7) |
3 (2,6) |
<0.001 |
| Proportion of mature oocytes (%) median (25th - 75th percentile) |
75.0 (57.1,100) |
66.7 (66.7,100) |
0.752 |
| Proportion of fertilized oocytes (%) median (25th - 75th percentile) |
71.4 (66.7, 80.0) |
66.7 (50.0,100) |
0.317 |
| Number of transferable embryos median (25th - 75th percentile) |
4 (2,4) |
2 (1,3) |
<0.001 |
| Proportion of patients with endometrium thickness >8 mm (%) | 80 | 69 | 0.190 |
| Implantation rate (%) | 8.9 | 4.4 | 0.125 |